This trial is designed to study the long-term effects of the drug phentermine on weight, blood pressure, and other health outcomes.
0 Primary · 4 Secondary · Reporting Duration: Month 1, Month 2, Month 3, Month 6, Month 9, Month 12, Month 15, Month 18, Month 21, Month 24
Experimental Treatment
Non-Treatment Group
1000 Total Participants · 2 Treatment Groups
Primary Treatment: Phentermine Hydrochloride 8 MG · Has Placebo Group · Phase 4
Age 18 - 70 · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Texas | 50.0% |
North Carolina | 22.2% |
California | 16.7% |
Other | 11.1% |
18 - 65 | 93.3% |
65+ | 6.7% |
Kaiser Permanente Southern California | 25.0% |
Atrium Health Wake Forest Baptist Weight Management Center | 25.0% |
UT Center for Obesity Medicine and Metabolic Performance | 41.7% |
Other | 8.3% |
Met criteria | 73.7% |
Did not meet criteria | 26.3% |
1 | 60.0% |
2 | 20.0% |
3+ | 20.0% |
Phone Call | 100.0% |